DXP-106

· Singlomics Biopharmaceuticals Zhuhai Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DXP-106, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: DXP-106 in Solid Tumor Patients. [Phase 1]